United States: Mintz IRA Update — Demystifying The IRA's Small Biotech Exception - Mintz
Monday, 4 March 2024
On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA's Medicare Drug Price Negotiation Program...
|
||||
You Might Like |
||||
